Methylation of the genes in the 9P21 region in children with acute myeloid leukemia.
- Author:
Li ZHANG
1
;
Min RUAN
;
Xiao-Ming LIU
;
Jia-Yuan ZHANG
;
Ye GUO
;
Wen-Yu YANG
;
Fang LIU
;
Tian-Feng LIU
;
Shu-Chun WANG
;
Xiao-Juan CHEN
;
Yao ZOU
;
Yu-Mei CHEN
;
Xiao-Fan ZHU
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Child; Child, Preschool; Cyclin-Dependent Kinase Inhibitor p15; genetics; Cyclin-Dependent Kinase Inhibitor p16; genetics; DNA Methylation; Female; Humans; Infant; Leukemia, Myeloid, Acute; genetics; Male
- From: Chinese Journal of Contemporary Pediatrics 2015;17(1):6-10
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the methylation rate of cyclin-dependent kinase inhibitor 2A (CDKN2A) and cyclin-dependent kinase inhibitor 2B (CDKN2B) in the 9P21 region in children with acute myeloid leukemia (AML) and the association of gene methylation with clinical features and outcomes.
METHODSThe clinical data of 58 children who were newly diagnosed with AML between January 2010 and December 2012 were retrospectively analyzed. Thirty-eight healthy children were recruited as the control group. Genomic DNA was extracted from bone marrow or peripheral blood of the 58 patients and 38 healthy children. The methylation status of CDKN2A and CDKN2B was analyzed by methylation-specific multiplex ligation-dependent probe amplification.
RESULTSGene methylation was not found in healthy children. Methylation probes of 44 patients were detected in 58 patients. The methylation of CDKN2A was detected with 136 bp and 237 bp methylation probes. The methylation of CDKN2B was detected with 130 bp, 210 bp, 220 bp, and 417 bp methylation probes. The methylation rate of CDKN2A was 5%, while the methylation rate of CDKN2B was 76%. The methylation detected by some probes was associated with sex, hemoglobin, and platelet count at the first visit.
CONCLUSIONSThe methylation of CDKN2B is a common event in children with AML, while the methylation of CDKN2A is relatively rare.